Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994

Leukemia volume 14, pages 2276–2285 (2000)Cite this article

Abstract

This paper presents the long-term results of treatment for children with acute lymphoblastic leukemia (ALL) as conducted by the Pediatric Oncology Group (POG) from 1986 to 1994. The data are presented using standard NCI/Rome risk criteria. The overall event-free survival (EFS) at 5 and 10 years were 70.9% and 67.3% for children with B-precursor ALL, 51.0% and 50.2% for patients with T cell ALL, and 22.4% and 20.9% for infants with ALL. Concomitant biologic studies found that in B-precursor ALL a DNA index (DI) of ⩾1.16 and trisomies of both chromosomes 4 and 10 were good prognostic indicators for patients with B-precursor ALL. The traditional prognostic indicators (age and white count), DI and trisomies did not predict outcome in patients with T cell disease. Infants continued to do poorly overall despite more intensive therapy with rotating pairs of chemotherapy. We recommend continued reporting of study results using common risk criteria in order to facilitate comparisons both within and across study groups.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Mastrangelo R, Poplack D, Bleyer A, Riccardi R, Sather H, D'Angio G . Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment Med Ped Oncol 1986 14: 191–194

    Article  CAS  Google Scholar 

  2. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui C-H, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia J Clin Oncol 1996 14: 18–24

    Article  CAS  Google Scholar 

  3. Land VJ, Shuster JJ, Crist WM, Ravindranath Y, Harris MB, Krance RA, Pinkel D, Pullen DJ . Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study J Clin Oncol 1994 12: 1939–1945

    Article  CAS  Google Scholar 

  4. Harris MB, Shuster JJ, Pullen J, Borowitz MJ, Carroll AJ, Behm FG, Land VJ . Consolidation therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study J Clin Oncol 1998 16: 2840–2847

    Article  CAS  Google Scholar 

  5. Harris MB, Shuster JJ, Pullen J, Borowitz MJ, Carroll AJ, Behm FG, Camitta BA, Land VJ . Treatment of children with early pre-B and pre-B acute lymphoblastic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group study Leukemia (in press)

  6. Mahoney DH, Shuster J, Nitschke R, Lauer SJ, Winick N, Steuber CP, Camitta BM . Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial J Clin Oncol 1998 16: 246–254

    Article  CAS  Google Scholar 

  7. Mahoney DH, Shuster JJ, Nitschke R, Lauer S, Steuber CP, Camitta BM . Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group study J Clin Oncol 2000 18: 1285–1294

    Article  CAS  Google Scholar 

  8. Harris MB, Shuster JJ, Carroll A, Look AT, Borowitz MJ, Crist WM, Nitschke R, Pullen J, Steuber CP, Land VJ . Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study Blood 1992 79: 3316–3324

    Article  CAS  Google Scholar 

  9. Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M, Katz J, Yu A, Laver J, Ravindranath Y, Kurtzberg J, Desai S, Camitta BM, Murphy SB . Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study Leukemia 1999 13: 335–342

    Article  CAS  Google Scholar 

  10. Frankel LS, Ochs J, Shuster JJ, Dubowy R, Bowman WP, Hockenberry-Eaton M, Borowitz M, Carroll AJ, Steuber CP, Pullen DJ . Therapeutic trail for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493) J Pediatr Hematol Oncol 1997 19: 35–42

    Article  CAS  Google Scholar 

  11. Lauer SJ, Camitta BM, Leventhal BG, Mahoney D, Shuster JJ, Kiefer G, Pullen J, Steuber CP, Carroll AJ, Kamen B . Intensive alternating drug pairs for treatment of infant acute lymphoblastic leukemia. A Pediatric Oncology Group study J Pediatr Hematol Oncol 1998 20: 229–233

    Article  CAS  Google Scholar 

  12. Lauer SJ, Shuster JJ, Mahoney DH, Winick N, Toledano S, Munoz L, Kiefer G, Pullen J, Steuber CP, Camitta BM . A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial (submitted)

  13. Peto R, Peto J . Asymptotically efficient rank invariant invariant test procedures J Roy Stat Assoc Ser A 1972 135: 185–198

    Article  Google Scholar 

  14. Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  15. Peto R, Pike M, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG . Design and analysis of randomized clinical trials requiring prolonged observation of each patient Br J Cancer 1977 35: 1–35

    Article  CAS  Google Scholar 

  16. Cox DR . Regression models and life-tables J Roy Stat Assoc Ser B 1972 34: 187–202

    Google Scholar 

  17. Kalbfleisch JD, Prentice RL . Statistical Analysis of Failure Time Data Wiley: New York 1980 pp 163–178

  18. Winick N, Shuster JJ, Bowman WP, Borowitz M, Farrow A, Jacaruso D, Buchanan GR, Kamen BA . Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia J Clin Oncol 1996 14: 2803–2811

    Article  CAS  Google Scholar 

  19. Kamps WA, Bokkerink JPM, Hakvoort-Cammel FGAJ, Weening RS, Veerman AJP, v Weerden JF, v Werring ER, vd Does-vd Berg A . Results of the DCLSG study ALL 8 (1991–1997): BFM oriented treatment without cranial irradiation and comparing conventional oral and high dose intravenous 6-mercaptopurine Med Ped Oncol 1999 33: 169

    Google Scholar 

  20. Goldie JH, Coldman AJ, Gudauskas GA . Rationale for the use of alternating non-cross-resistant chemotherapy Cancer Treat Rep 1982 66: 439–449

    CAS  Google Scholar 

  21. Crist WM, Carroll AJ, Shuster JJ, Behm FG, Whitehead M, Vieti TJ, Look AT, Mahoney D, Ragab A, Pullen DJ, Land VJ . Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13). A Pediatric Oncology Group study Blood 1990 76: 117–122

    Article  CAS  Google Scholar 

  22. Raimondi SC, Behm FG, Roberson PK, Williams DL, Pui C-H, Crist WM, Look AT, Rivera GK . Cytogenetics of pre-B cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19) J Clin Oncol 1990 8: 1380–1388

    Article  CAS  Google Scholar 

  23. Crist W, Carroll A, Shuster J, Jackson J, Head D, Borowitz M, Behm F, Link M, Ragab A, Hirt A, Brock B, Land V, Pullen J . Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study Blood 1990 76: 489–494

    Article  CAS  Google Scholar 

  24. Arico M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kams W, Pui CH, Masera G . Outcome of treatment in children with Philadelphia-positive acute lymphoblastic leukemia New Engl J Med 2000 342: 998–1006

    Article  CAS  Google Scholar 

  25. Trueworthy R, Shuster JJ, Look T, Crist W, Borowitz M, Carroll A, Frankel L, Harris M, Wagner H, Haggard M, Mosijczuk A, Pullen J, Steuber P, Land V . Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study J Clin Oncol 1992 10: 606–613

    Article  CAS  Google Scholar 

  26. Look AT, Roberson PK, Williams DL, Rivera G, Bowman WP, Pui C-H, Ochs J, Abromowitch M, Kalwinsky D, Dahl GV, George S, Murphy SB . Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia Blood 1985 65: 1079–1086

    Article  CAS  Google Scholar 

  27. Hiddemann W, Harbott J, Ludwig W-D, Ritter J, Nehmer A, Reiter A, Kolkmeyer A, Laing T, Riehm H . DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials Rec Res Cancer Res 1994 131: 113–120

    Article  Google Scholar 

  28. Heerema NA, Sather HN, Sensel MG, Zhang T, Hutchingson RJ, Nachman JB, Lange BJ, Steinberz PG, Bostrom BC, Reaman GH, Gaynon PS, Uckun FM . Prognostic impact of trisomies of chromosomes 10, 17 and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes) J Clin Oncol 2000 18: 1876–1887

    Article  CAS  Google Scholar 

  29. Borowitz MJ, Rubnitz J, Nash M, Pullen DJ, Camitta BM . Surface antigen phenotype can predict TEL-AML 1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study Leukemia 1998 12: 1764–1770

    Article  CAS  Google Scholar 

  30. Pollock BH, DeBaun MR, Camitta BM, Shuster JJ, Ravindranath Y, Pullen JD, Land VJ, Mahoney DH, Lauer SJ, Murphy SB . Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group study J Clin Oncol 2000 18: 813–823

    Article  CAS  Google Scholar 

  31. Shuster JJ, Wacker P, Pullen J, Humbert J, Land VJ, Mahoney DH, Lauer S, Look AT, Borowitz MJ, Carroll AJ, Camitta BM . Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group study J Clin Oncol 1998 16: 2854–2863

    Article  CAS  Google Scholar 

  32. Reiter A, Schrappe M, Ludwig W-D, Hiddermann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H . Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL-BFM 86 Blood 1994 84: 3122–3133

    Article  CAS  Google Scholar 

  33. Kurtzberg J, Ernst TJ, Keating MJ, Gandhi V, Hodge JP, Kisor DF, Therriault R, Stephens C, Levin J, Krenitsky T, Elion GB, Mitchell BS . A phase I study of 2-amino-9-B-D-arabinosyl-6-methosy-9H-purine (506U78) administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies Blood 1999 94: 629a

    Google Scholar 

  34. Pullen J, Shuster JJ, Link M, Borowitz M, Amylon M, Carroll AJ, Land V, Look AT, McIntyre B, Camitta B . Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study Leukemia 1999 13: 1696–1707

    Article  CAS  Google Scholar 

  35. Dreyer ZE, Steuber CP, Bowman WP, Murray JC, Coppes MJ, Dinndorf P, Camitta B . High risk infant ALL – improved survival with intensive chemotherapy ASCO Proc 1998 17: 529a

    Google Scholar 

  36. Mahoney DH, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N, Camitta BM . Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy–a pediatric oncology group study J Clin Oncol 1998 16: 1712–1722

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by NIH grants: CA32053, CA29139, CA30969, CA07431 and CA15989.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Midwest Children's Cancer Center, Milwaukee, WI

    KW Maloney & BA Camitta

  2. Pediatric Oncology Group Statistical Office and Department of Statistics, University of Florida Gainesvillez, FL

    JJ Shuster

  3. Department of Hematology/Oncology, Children's Memorial Hospital and the Department of Pediatrics, Northwestern University Medical School, Chicago, IL

    S Murphy

  4. Department of Pediatrics, University of Mississippi Medical Center, Children's Hospital, Jackson, MS, USA

    J Pullen

Authors
  1. KW Maloney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. JJ Shuster
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Pullen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. BA Camitta
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maloney, K., Shuster, J., Murphy, S. et al. Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994. Leukemia 14, 2276–2285 (2000). https://doi.org/10.1038/sj.leu.2401965

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401965

Keywords

This article is cited by

Search

Advanced search

Quick links